Based in Florida, Curative Biosciences, Inc., (stock symbol CBDX) combines research capacities with a full portfolio of CBD products, encompassing soft gels, oils, and topicals. Committed to developing health products that are scientifically sound, Curative Biosciences, Inc., has a proactive approach to taking the latest science and technology advances and translating them into organic, non-GMO products that are additive- and chemical pesticide-free.
The extensive Curative Biosciences research network addresses critical health issues such as nausea, cancer, diabetes, and nerve damage. Each intensively tested product includes whole-plant extracts that contain a full complement of natural and safe terpenes and cannabinoids. Maximizing bioavailability and offering a full spectrum profile, the products do not contain the psychoactive compound THC.
With a globally oriented marketing and distribution base, Curative Biosciences, Inc., has a focus on providing its quality CBD products to customers across the United States, as well as in more than three dozen countries worldwide. Its portfolio represents a dynamic and expanding health industry category with abundant opportunities for growth.